Oral Active Carbon Quantum Dots for Diabetes
Based on these results, the products have potential therapeutic advantages in diabetes management through their increased efficacy and may have reduced side effects compared to the control group.
Authors
- Eduardo Sobarzo‐Sánchez (ORCID: https://orcid.org/0000-0002-2790-2544)
- Gamze Çamlık (ORCID: https://orcid.org/0000-0003-3282-8307)
- Esra Küpeli Akkol (ORCID: https://orcid.org/0000-0002-5829-7869)
- İsmail Tuncer Değim (ORCID: https://orcid.org/0000-0002-9329-4698)
- Adrian Joshua Velaro (ORCID: https://orcid.org/0000-0002-5871-6728)
- Besa Bilakaya (ORCID: https://orcid.org/0000-0001-9510-4467)
- Adi Muradi Muhar (ORCID: https://orcid.org/0000-0002-5288-304X)
- Siddhanshu Wasnik (ORCID: https://orcid.org/0000-0003-2177-2125)
Institutions
- Universidade de Santiago de Compostela (ES)
- Universitas Sumatera Utara (ID)
- Government Medical College and Hospital (IN)
- Biruni University (TR)
- Universidad Central de Chile (CL)
- Gazi University (TR)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2024-10-19
- DOI
- https://doi.org/10.3390/ph17101395
- Citations
- 16
- Primary Topic
- Carbon and Quantum Dots Applications
- Type
- article
- Field-Weighted Citation Impact
- 1.87